The National Institute of Biomedical Imaging and Bioengineering, under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) federal grant program, awarded a $629,495 Project Grant (R01EB034902) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop and evaluate an inexpensive brain monitoring device using low-field magnetic resonance imaging (MRI) technology. The goal is to create a portable,...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering, under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program, is funding research and development of a novel wireless pressure sensor system to monitor intracranial pressure in patients with neurological conditions.
The $495,977 award supports the development and long-term in vitro testing of a membrane-based pressure microsensor...
This Project Grant award under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, administered by the National Institute of Neurological Disorders and Stroke (NINDS), is funding the development of a highly parallelized interferometric near-infrared spectroscopy (INIRS) system for the real-time, non-invasive measurement of cerebral blood flow (CBF).
The $498,995 award to Neuralenz, Inc. aims to create an integrated platform called...
This $580,654 project grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program aims to develop an advanced optical imaging system to quantitatively measure cerebral blood flow in patients with subarachnoid hemorrhage. The project will leverage a new interferometric diffuse optics (IDO) approach to provide highly parallel detection, time-of-flight...
The General Hospital Corporation Research Management Division (MGH), doing business as Massachusetts General Hospital, received a $601,970 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The funding supports the development and evaluation of an inexpensive "brain monitor" device using low-field magnetic resonance...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development of an innovative, portable diagnostic device to quickly detect and monitor traumatic brain injury (TBI) biomarkers.
The $332,122 award to Hemex Health Inc., a for-profit medical device manufacturer, will fund the creation of a point-of-care platform that can...
This federal Cooperative Agreement award, funded by the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health), provides $422,619 to Trustees of Boston University to advance high-density wearable functional near-infrared spectroscopy (fNIRS) systems. The project aims to improve the sensitivity and inclusiveness of fNIRS measurements to enable continuous tracking of human brain function and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $704,313 to Boston University Medical Campus to advance a prognostic and monitoring biomarker for neutrophil-driven secondary brain injury in spontaneous intracerebral hemorrhage. The project aims to define and validate a standardized protocol to detect a specific neutrophil...
The National Science Foundation awarded a $266,000 Project Grant to Columbia University under the NSF Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a wearable noninvasive brain imaging device using near-infrared light-based time-domain diffuse optical tomography. The device aims to improve clinical outcomes in neurology by enabling measurement of deep brain blood flow, which is difficult to measure with current technologies. The grant will support...
This $127,465 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program aims to develop a next-generation photoacoustic computed tomography device for noninvasive monitoring of cerebral metabolic rate of oxygen (CMRO2). The device will integrate technologies such as acoustic impedance-matching layers, longer-wavelength illumination, and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is funding the development of a low-cost, high-performance near-infrared spectroscopy (NIRS) and speckle contrast optical spectroscopy (SCOS) device. This device is designed for non-invasive monitoring of cerebral blood flow and intracranial pressure in patients with traumatic brain injury. The $677,014 award to The General Hospital Corporation (Massachusetts General Hospital) aims to improve access to intracranial pressure monitoring, enabling faster triage and more effective treatment of trauma patients. The project includes a $77,436 sub-award to Boston University to develop the SCOS data correction and analysis pipeline. The award duration is from June 1, 2024 to May 31, 2029.